Research Paper Volume 12, Issue 19 pp 19335—19351
TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
FREM1 expression levels in different types of human cancers. (A) Expression levels of FREM1 in different types of cancer compared with normal tissues. Data is from the Oncomine database. (B) Expression levels of FREM1 in different tumor types from the TCGA database were analyzed by TIMER. (C, D) FREM1 expression levels analyze by TIMER in normal and tumor samples from the TCGA and GEO databases. (E, F) FREM1 expression levels were analyzed by Q-PCR in paired normal and tumor tissues. (G, H) FREM1 expression levels in normal and subtypes of breast cancer samples from the TCGA and GEO databases were analyzed by TIMER. (*P <0.05, ** P < 0.01, ***P < 0.001).